Netherton; Matthew Russell
Patent Applications and Registrations
Patent applications and USPTO patent grants for Netherton; Matthew Russell.The latest application filed is for "novel benzylamino substituted quinazolines and derivatives as sos1 inhibitors".
- Netherton; Matthew Russell - Danbury CT
- Netherton; Matthew Russell - Cambridge MA
- Netherton; Matthew Russell - Ridgebury CT
| Patent | Date |
|---|---|
| Inhibitors of TRPC6 Grant 11,370,771 - Berry , et al. June 28, 2 | 2022-06-28 |
| Novel Benzylamino Substituted Quinazolines And Derivatives As Sos1 Inhibitors App 20210177851 - GMACHL; Michael ; et al. | 2021-06-17 |
| Inhibitors Of Trpc6 App 20210053935 - BERRY; Angela Kay ; et al. | 2021-02-25 |
| Benzylamino substituted quinazolines and derivatives as SOS1 inhibitors Grant 10,898,487 - Kessler , et al. January 26, 2 | 2021-01-26 |
| Methods And Compounds For Treating Disorders App 20210009568 - Zhou; Qianhe ; et al. | 2021-01-14 |
| Novel Benzylamino Substituted Quinazolines And Derivatives As Sos1 Inhibitors App 20190358230 - GMACHL; Michael ; et al. | 2019-11-28 |
| Benzodioxane inhibitors of leukotriene production Grant 9,133,146 - Abeywardane , et al. September 15, 2 | 2015-09-15 |
| Benzodioxane inhibitors of leukotriene production Grant 8,946,203 - Abeywardane , et al. February 3, 2 | 2015-02-03 |
| Heteroaryl nitrile compounds useful as inhibitors of Cathepsin-S Grant 8,729,114 - Burke , et al. May 20, 2 | 2014-05-20 |
| Benzodioxane Inhibitors Of Leukotriene Production App 20130345195 - ABEYWARDANE; Asitha ; et al. | 2013-12-26 |
| Benzodioxane inhibitors of leukotriene production Grant 8,551,982 - Abeywardane , et al. October 8, 2 | 2013-10-08 |
| Benzodioxane Inhibitors Of Leukotriene Production App 20130244996 - ABEYWARDANE; Asitha ; et al. | 2013-09-19 |
| Benzodioxane Inhibitors Of Leukotriene Production App 20130196973 - Abeywardane; Asitha ; et al. | 2013-08-01 |
| Heteroaryl Nitrile Compounds Useful as Inhibitors of Cathepsin-S App 20130158018 - Burke; Michael J. ; et al. | 2013-06-20 |
| Substituted [1,4]diazepino[1,2-A]indoles and azepino[1,2-A]indoles as anti-cytokine inhibitors Grant 7,790,712 - Cogan , et al. September 7, 2 | 2010-09-07 |
| Anti-Cytokine Heterocyclic Compounds App 20100190773 - ABEYWARDANE; Asitha ; et al. | 2010-07-29 |
| Anti-cytokine heterocyclic compounds Grant 7,531,560 - Cogan , et al. May 12, 2 | 2009-05-12 |
| Anti-cytokine heterocyclic compounds Grant 7,514,458 - Cogan , et al. April 7, 2 | 2009-04-07 |
| Triazole compounds Grant 7,511,042 - Cogan , et al. March 31, 2 | 2009-03-31 |
| Cytokine inhibitors Grant 7,335,657 - Cirillo , et al. February 26, 2 | 2008-02-26 |
| Anti-Cytokine Heterocyclic Compounds App 20070142371 - Cogan; Derek ; et al. | 2007-06-21 |
| Anti-cytokine heterocyclic compounds Grant 7,214,802 - Cogan , et al. May 8, 2 | 2007-05-08 |
| Cytokine Inhibitors App 20060235017 - Cirillo; Pier Francesco ; et al. | 2006-10-19 |
| Cytokine inhibitors Grant 7,078,419 - Cirillo , et al. July 18, 2 | 2006-07-18 |
| Anti-cytokine heterocyclic compounds App 20060100204 - Cogan; Derek ; et al. | 2006-05-11 |
| Anti-cytokine heterocyclic compounds App 20060079519 - Cogan; Derek ; et al. | 2006-04-13 |
| Triazole compounds App 20050153972 - Cogan, Derek ; et al. | 2005-07-14 |
| Cytokine inhibitors App 20040186114 - Cirillo, Pier Francesco ; et al. | 2004-09-23 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 